Advertisment
 

Join the Topix community today: 

Sign Up

 | 

Sign In

updated: Tue Jul 08, 2008 02:46 am

GlaxoSmithKline News

News on GlaxoSmithKline continually updated from thousands of sources around the net.

18 hrs ago | PR-inside.com

GlaxoSmithKline plc - PharmaVitae Profile - New Research Report on Companies and Markets

The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Jul 07, 2008

MediLexicon

Adolor Provides Update On Entereg (alvimopan) Obd Program - Fda Lifts Clinical Hold On Obd Ind

Main Category: GastroIntestinal / Gastroenterology Also Included In: Clinical Trials / Drug Trials Adolor Corporation today issued an update on the Entereg Program for chronic opioid bowel dysfunction , under ...

Comment?

Related Topix: Biotech, Healthcare Law, Food and Drug Administration, Law, Adolor, Medicine, Healthcare Industry

Sun Jul 06, 2008

News Observer

GSK, Novartis plan to appeal verdict

Two large pharmaceutical companies said Thursday they will appeal a jury verdict ordering them to pay more than $114 million for overcharging the state's Medicaid program for prescription drugs.

Comment?

Related Topix: Biotech, Medicaid, Health

Sat Jul 05, 2008

MediLexicon

GSK Does Not Expect FDA Approval Of HPV Vaccine Cervarix Until End Of 2009

Main Category: Cervical Cancer / HPV Vaccine Also Included In: Regulatory Affairs / Drug Approvals Article Date: 03 Jul 2008 GlaxoSmithKline on Monday said it does not expect to receive FDA approval for its ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cervical Cancer, Health, Food and Drug Administration

Fri Jul 04, 2008

GuruFocus.com

GlaxoSmithKline plc (GSK): Bill Nygren Initiates Holdings in GSK

GuruFocus Home >> Stock Ideas >> Recent Picks >> Glaxosmithkline Plc GSK - GlaxoSmithKline plc $117.2 Bil 18.69% 52.22% 6.3 33.19% 2.58 23.01% 4.94% $0 2664.26 Mil GlaxoSmithKline is one of the world's leading ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

WLOX

2 firms to appeal $114M verdict in drug case

Drug companies GlaxoSmithKline and Novartis say they will appeal a jury verdict ordering them to pay more than $114 million to Alavbama for overcharging the state's Medicaid program for prescription drugs.

Comment?

Related Topix: Biotech, Healthcare Law, Law, Medicaid, Health

Thu Jul 03, 2008

Medical News Today

Long-Term Study Of Middle-Aged Mice Shows Resveratrol...

Main Category: Diabetes Also Included In: Cardiovascular / Cardiology Article Date: 03 Jul 2008 - 13:00 PDT Sirtris, a GlaxoSmithKline company focused on discovering and developing small molecule drugs to treat ...

Comment?

Related Topix: Biotech, Medicine, Cataract, Health

Medical News Today

GlaxoSmithKline, Novartis Found Guilty Of Overcharging Alabama Medicaid Program, Must Pay State $114M

Main Category: Medicare / Medicaid / SCHIP Also Included In: Pharma Industry / Biotech Industry ; Medical Malpractice / Litigation Article Date: 03 Jul 2008 - 6:00 PDT An Alabama state court jury on Tuesday ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Health

Med Ad News

Adolor Provides Update on Entereg (alvimopan) OBD Program

Jul 3, 2008 - Adolor Corporation today issued an update on the Entereg Program for chronic opioid bowel dysfunction , under development in collaboration with GlaxoSmithKline .

Comment?

Related Topix: Biotech, Healthcare Law, Food and Drug Administration, Law, Adolor, Medicine, Healthcare Industry

Wed Jul 02, 2008

The Washington Post

FDA panel urges more testing for diabetes drugs

By MATTHEW PERRONE The Associated Press Wednesday, July 2, 2008; 4:31 PM WASHINGTON -- Diabetes drugs would be subject to more stringent safety standards that could cost manufacturers millions, under ...

Comment?

Related Topix: Food and Drug Administration, Diabetes, Health, Biotech, Healthcare Industry

Fool.com

A Drug to End Merck's Headache?

But Merck was able to relieve some of those headaches on Friday by presenting pretty good data for its phase 3 migraine drug, telcagepant.

Comment?

Related Topix: Medicine, Headache, Health, Biotech, AstraZeneca Group, Zomig, Zolmitriptan (generic), Medication, Migraine, Imitrex, Sumatriptan (generic)

SmartMoney

Genmab Reaches Milestone In Ofatumumab Collaboration

Genmab said Monday it has reached a development milestone for ofatumumab under the terms of its collaboration with GlaxoSmithKline .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Jul 01, 2008

Montgomery Advertiser

Jury Favors Alabama in Drug Suit

A jury in Montgomery County Circuit Court returned a verdict in favor of the State of Alabama, finding defendants, GlaxoSmithKline and Novartis Pharmaceuticals Corp.

Comment?

Related Topix: Biotech, Montgomery County, AL, Healthcare Law, Law, Alabama, Alabama Government

News-Medical.Net

Smoking ban triggered the biggest fall in smoking ever seen in England

Smokefree law in England has helped more smokers to quit than ever before and will help prevent an estimated 40,000 deaths over the next 10 years - according to new research being presented in Birmingham ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Health, Lung Cancer, Smoking

BioSpace

Exelixis, Inc. and GlaxoSmithKline Agree to Successfully Conclude...

Exelixis, Inc. announced today that the company and GlaxoSmithKline, Inc. will bring their six-year collaboration to a successful conclusion on October 27, 2008, as scheduled.

Comment?

Related Topix: Biotech, Exelixis, Medicine, Healthcare Industry

Mon Jun 30, 2008

IBJ.COM

Ala. lawyer asks jury for $800M in drug fraud case

An attorney for Alabama asked jurors Monday to award the state as much as $800 million from two pharmaceutical companies accused of overcharging for Medicaid drugs.

Comment?

Related Topix: East Hanover, NJ, Healthcare Law, Law, Biotech, Medicine, Healthcare Industry

Triangle Business Journal

GlaxoSmithKline sets date for data on key drug

GlaxoSmithKline expects to submit new data on its cervical-cancer vaccine, Cervarix, in the first half of 2009, the company said Monday.

Comment?

Related Topix: Cervical Cancer, Health, Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Merck

Sun Jun 29, 2008

Reuters

Gates-backed vaccine investor eyes HPV and rubella

GENEVA - An international partnership that funds vaccines for children in poor countries will decide on Wednesday whether to also start investing in vaccinations to protect adult women.The ...

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry

Sat Jun 28, 2008

Newsday.com

Panel endorses new combo vaccines for children

ATLANTA - A federal advisory panel yesterday endorsed two new combination vaccines designed to reduce the number of jabs young children must endure to get the recommended immunizations.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri Jun 27, 2008

Philadelphia Business Journal

Exelixis, GlaxoSmithKline collaboration ending

A collaboration between Exelixis Inc. and GlaxoSmithKline will conclude at the end of October.

Comment?

Related Topix: Startups, Exelixis, Biotech, Medicine, Healthcare Industry, San Francisco Metro

↑ Back to top

More GlaxoSmithKline News

Archives

Read more articles in the GlaxoSmithKline News Archives.

For up to the minute news, check out the GlaxoSmithKline News Wire.

Want to add GlaxoSmithKline News headlines to your web site? Get the widget here.

GlaxoSmithKline News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make GlaxoSmithKline News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

GlaxoSmithKline Photos

Topix Quick Poll

created by: Groucho | Friday Jun 27

Click on an option to vote

3,423

votes

  • $5.00
  • $6.00
  • $7.00
  • $8.00
  • $9.00
  • $10.00
  • To the moon, Alice!

Los Angeles Jobs